Table 2.
The association between lifestyle at diagnosis and inflammatory marker levels six months after diagnosis in colorectal cancer patients.
| Inflammation 6 Months after Diagnosis | N | Crude Beta 95% CI |
Adjusted * Beta 95% CI |
|
|---|---|---|---|---|
| IL6 | ||||
| WCRF/AICR-score | 607 | −0.11 (−0.19; −0.04) | −0.10 (−0.17; −0.03) | |
| IL8 | ||||
| WCRF/AICR-score | 609 | −0.05 (−0.10; −0.00) | −0.05 (−0.09; 0.00) | |
| TNFα | ||||
| WCRF/AICR-score | 611 | −0.08 (−0.11; −0.05) | −0.07 (−0.10; −0.04) | |
| hsCRP | ||||
| WCRF/AICR-score | 1116 | −0.20 (−0.28; −0.13) | −0.20 (−0.28; −0.12) | |
* adjusted for age, sex, stage of disease, chemotherapy (yes/no) and cohort. To interpret the beta coefficient of the regression line, the exponential of the beta should be taken (EXPβ), since a natural log transformation was done on the outcome variable.